Effectiveness and safety of PCSK9 inhibitors in real-world clinical practice. An observational multicentre study. The IRIS-PCSK9I study

enthalten in: Atherosclerosis plus | 2021

von Blanco-Ruiz, M. | Amaya-Pascasio, L. | de Torres Chacón, R. | +19